Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

Published:2014-10-20 Issue:12 Volume:16 Page:875-882
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Weir Matthew R.¹,Januszewicz Andrzej²,Gilbert Richard E.³,Vijapurkar Ujjwala⁴,Kline Irina⁴,Fung Albert⁴,Meininger Gary⁴

Affiliation:

1. Division of Nephrology; Department of Medicine; University of Maryland School of Medicine; Baltimore MD

2. Department of Hypertension; Institute of Cardiology; Warsaw Poland

3. University of Toronto; St. Michael's Hospital; Toronto ON Canada

4. Janssen Research & Development; LLC; Raritan NJ

Funder

Janssen Research & Development, LLC

Janssen Global Services

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12425/fullpdf

Reference19 articles.

1. Centers for Disease Control and Prevention 2011 National Diabetes Fact Sheet http://www.cdc.gov/diabetes/pubs/factsheet11.htm

2. Diabetes and hypertension: the bad companions;Ferrannini;Lancet,2012

3. Standards of medical care in diabetes-2013;American Diabetes Association;Diabetes Care,2013

4. Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: a randomized trial;Bode;Hosp Pract.,2013

5. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial;Cefalu;Lancet,2013

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT-2 inhibitors: new horizons for rheumatologists;Current Opinion in Rheumatology;2024-07-16

2. Euglycemic diabetic ketoacidosis due to small bowel perforation: a case report;Emergency Care Journal;2024-06-19

3. Antihypertensive Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists;Cardiology Discovery;2024-02-14

4. SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes;Renal Replacement Therapy;2024-01-31

5. Paris polyphylla Sm. extract enriched with diosgenin as an antidiabetic agent: In vitro and in vivo study;Phytomedicine Plus;2023-11